Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266565 · ClinicalTrials.gov registry record · Phase 1
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
A Phase 1 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00266565 is a Phase 1 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 24 participants.
The verdict
NCT00266565, a Phase 1 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
Toxicity of anti-IL-5
Interventions
- DRUG Mepolizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2001-12 |
| Est. Completion | 2005-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00266565
The ClinicalTrials.gov registry entry for NCT00266565 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mepolizumab is the first listed.
NCT00266565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00266565 about?
NCT00266565 is a clinical study titled "Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome". Toxicity of anti-IL-5
What is the current status of trial NCT00266565?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2001-12. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00266565?
The interventions under investigation include: Mepolizumab (DRUG).
Who is sponsoring clinical trial NCT00266565?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.